Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhishin Capital is a China-based venture capital and private equity firm that focuses exclusively on the healthcare and life sciences industries. Established in 2015, the firm invests in a broad range of sectors including innovative drug development, medical devices, in-vitro diagnostics, and healthcare services. Zhishin Capital targets companies at various stages of development, from early-stage startups to growth-phase enterprises, primarily within the Chinese market. The firm leverages its deep industry expertise and extensive network to provide strategic guidance and operational support to its portfolio companies. Its mission is to foster healthcare innovation and improve patient outcomes by backing transformative medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhishin Capital.